Inovio Pharmaceuticals Inc. (INO) reported a reduced net loss for the second quarter compared to the same period last year.
The company's net loss amounted to $32.24 million, or $1.19 per share, compared to a net loss of $35.53 million, or $1.61 per share, in the second quarter of the previous year.
Revenue for the quarter dropped by 55.6% to $0.1 million, down from $0.225 million in the comparable quarter last year.
Key earnings highlights for Inovio Pharmaceuticals Inc. (According to GAAP):
- Net Loss (Q2): $32.24 million vs. $35.53 million last year
- Earnings Per Share (EPS, Q2): $1.19 loss vs. $1.61 loss last year
- Revenue (Q2): $0.1 million vs. $0.225 million last year
